August 21, 2015
Eli Lilly Japan said on August 21 that it has filed a lawsuit to reverse a ruling delivered by the Japan Patent Office (JPO) in April to invalidate the company’s usage patent for Evista (raloxifene), a treatment for osteoporosis in...read more